DNA (cytosine-5)-methyltransferase 3A

DNA (cytosine-5)-methyltransferase 3A

Simplified domains of DNMT3A isoforms

DNA (cytosine-5)-methyltransferase 3A (DNMT3A) is an enzyme that plays a crucial role in the epigenetic regulation of gene expression in eukaryotic cells. It is part of the DNA methyltransferase family, which is responsible for adding a methyl group to the 5th carbon of the cytosine ring in DNA, a process known as DNA methylation. This modification is essential for normal development, genomic imprinting, and X-chromosome inactivation.

Structure

DNMT3A is a large protein that contains several functional domains. The N-terminal region includes a PWWP domain and an ADD domain, which are involved in targeting the enzyme to specific regions of the genome. The C-terminal region contains the catalytic domain responsible for the transfer of methyl groups to DNA. DNMT3A can form complexes with other proteins, such as DNMT3B and DNMT3L, to enhance its activity and specificity.

Function

The primary function of DNMT3A is to establish new methylation patterns during embryogenesis and in stem cells. It is also involved in the maintenance of methylation patterns in somatic cells. DNMT3A works in conjunction with DNMT1, which is responsible for maintaining methylation patterns during DNA replication.

Biological Significance

DNA methylation is a key epigenetic mechanism that regulates gene expression without altering the DNA sequence. It is involved in various biological processes, including cell differentiation, genomic imprinting, and X-chromosome inactivation. Abnormal methylation patterns are associated with several diseases, including cancer, neurological disorders, and immunological diseases.

Clinical Implications

Mutations in the DNMT3A gene have been implicated in various types of cancer, including acute myeloid leukemia (AML). These mutations often result in a loss of function, leading to aberrant methylation patterns and altered gene expression. DNMT3A mutations are also associated with poor prognosis in AML patients.

Interactions

Heterotetramer of DNMTs 3A2 and 3B3 and its interactions with nucleosome and linker DNA

DNMT3A interacts with several proteins to modulate its activity and specificity. It forms a complex with DNMT3B and DNMT3L, which enhances its ability to methylate DNA. DNMT3A also interacts with histone-modifying enzymes, such as histone deacetylases (HDACs), to coordinate DNA methylation with histone modifications.

Related Pages

• DNA methylation
• Epigenetics
• DNA methyltransferase
• Acute myeloid leukemia